Laboratory strengthening strategies to advance drug susceptibility testing for BPaL regimens in TB treatment
Our study highlights the need for continued investment in training and infrastructure to integrate DST into routine diagnostics and to support scale-up of BPaL regimens in high TB-burden settings.
Authors
- Andrii Slyzkyi
- S. N. Cho (ORCID: https://orcid.org/0009-0007-8486-4568)
- D. F. Wares (ORCID: https://orcid.org/0000-0002-3283-9965)
- Junho Jung (ORCID: https://orcid.org/0000-0002-7007-0974)
- John Lee (ORCID: https://orcid.org/0000-0001-7698-3830)
Institutions
- TuBerculosis Vaccine Initiative (NL)
- International Tuberculosis Research Center (KR)
Publication Details
- Journal
- Public Health Action
- Published
- 2025-12-01
- DOI
- https://doi.org/10.5588/pha.25.0014
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00